CL2008001449A1 - Metodo para estimular la produccion de celulas hematopoyeticas diferenciadas en un cultivo que comprende celulas progenitoras hematopoyeticas, linfocitos y monocitos/macrofagos y/o celulas dendriticas en presencia de una molecula de union especifica para una molecula coestimuladora expresada en dichas celulas. - Google Patents

Metodo para estimular la produccion de celulas hematopoyeticas diferenciadas en un cultivo que comprende celulas progenitoras hematopoyeticas, linfocitos y monocitos/macrofagos y/o celulas dendriticas en presencia de una molecula de union especifica para una molecula coestimuladora expresada en dichas celulas.

Info

Publication number
CL2008001449A1
CL2008001449A1 CL2008001449A CL2008001449A CL2008001449A1 CL 2008001449 A1 CL2008001449 A1 CL 2008001449A1 CL 2008001449 A CL2008001449 A CL 2008001449A CL 2008001449 A CL2008001449 A CL 2008001449A CL 2008001449 A1 CL2008001449 A1 CL 2008001449A1
Authority
CL
Chile
Prior art keywords
cells
hematopoietic
monocytes
macrophages
lymphocytes
Prior art date
Application number
CL2008001449A
Other languages
English (en)
Inventor
Stef Meers
Original Assignee
Pangenetics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38846927&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008001449(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pangenetics Bv filed Critical Pangenetics Bv
Publication of CL2008001449A1 publication Critical patent/CL2008001449A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/52—CD40, CD40-ligand (CD154)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Método para estimular la producción de células hematopoyéticas diferenciadas en un cultivo que comprende células progenitoras hematopoyéticas, linfocitos y monocitos/macrófagos y/o células dendríticas en presencia de una molécula de unión específica para una molécula coestimuladora expresada en dichas células.
CL2008001449A 2007-05-16 2008-05-16 Metodo para estimular la produccion de celulas hematopoyeticas diferenciadas en un cultivo que comprende celulas progenitoras hematopoyeticas, linfocitos y monocitos/macrofagos y/o celulas dendriticas en presencia de una molecula de union especifica para una molecula coestimuladora expresada en dichas celulas. CL2008001449A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2007/050228 WO2008140296A1 (en) 2007-05-16 2007-05-16 Means and methods for enhancing differentiation of haematopoietic progenitor cells

Publications (1)

Publication Number Publication Date
CL2008001449A1 true CL2008001449A1 (es) 2010-08-27

Family

ID=38846927

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008001449A CL2008001449A1 (es) 2007-05-16 2008-05-16 Metodo para estimular la produccion de celulas hematopoyeticas diferenciadas en un cultivo que comprende celulas progenitoras hematopoyeticas, linfocitos y monocitos/macrofagos y/o celulas dendriticas en presencia de una molecula de union especifica para una molecula coestimuladora expresada en dichas celulas.

Country Status (9)

Country Link
US (1) US20100316632A1 (es)
JP (1) JP2010526554A (es)
KR (1) KR20100031503A (es)
AR (1) AR066627A1 (es)
BR (1) BRPI0811230A2 (es)
CA (1) CA2687266A1 (es)
CL (1) CL2008001449A1 (es)
TW (1) TW200904827A (es)
WO (2) WO2008140296A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG177651A1 (en) 2009-07-13 2012-03-29 Biogencell Ltd Method for using directing cells for specific stem/progenitor cell activation and differentiation
WO2013109104A1 (ko) * 2012-01-19 2013-07-25 서울대학교 산학협력단 인간 혈액 유래 혈구 세포괴를 포함하는 약학적 조성물
US8956870B2 (en) 2012-01-19 2015-02-17 Biogencell, Ltd. Method for using directing cells for specific stem/progenitor cell activation and differentiation
DE13746292T1 (de) * 2012-02-10 2014-10-30 Hakushinkouseikai Foundation Proliferationsmittel für monozyten, kulturmedium zur proliferation von monozyten, verfahren zur herstellung von monozyten, verfahren zur herstellung dendritischer zellen und verfahren zur herstellung eines impfstoffs mit dendritischen zellen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002540764A (ja) * 1999-02-12 2002-12-03 ジェネティックス・インスチチュート・インコーポレーテッド Ｂ７分子と反応するヒト化免疫グロブリンおよびそれを用いた治療方法

Also Published As

Publication number Publication date
KR20100031503A (ko) 2010-03-22
AR066627A1 (es) 2009-09-02
CA2687266A1 (en) 2008-11-20
TW200904827A (en) 2009-02-01
WO2008140316A1 (en) 2008-11-20
US20100316632A1 (en) 2010-12-16
BRPI0811230A2 (pt) 2014-10-21
JP2010526554A (ja) 2010-08-05
WO2008140296A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
MY157165A (en) Cross-linkers and their uses
EP2496700A4 (en) NUCLEIC ACID-CONTAINING FAT PARTICULARS AND CORRESPONDING METHODS
MY159971A (en) Multipotent/pluripotent cells and methods
WO2008148105A8 (en) Endometrial stem cells and methods of making and using same
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
ATE526394T1 (de) Verfahren zur expansion von cd4+ cd25+ t regulatory zellen
AU315626S (en) Stand
MX2010007716A (es) Combinacion de una proteina de fusion del anticuerpo-il-2 de anti-edb fibronectina y una molecula que se une a celulas b, progenitores de la celula b y/o sus contrapartes cancerigenas.
WO2009102569A3 (en) Cell lines and methods for making and using them
AU322444S (en) Adjustable wrecking bar
ATE452149T1 (de) Modifizierte polyolefinwachse
CL2012002871A1 (es) Metodo para identificar una población de celulas tr1 en reposo que comprende la deteccion de la expresion en la superficie celular de los marcadores cd4, cd25, cd127 y cd62l; poblacion aislada de celulas tr1; metodo para disminuir una poblacion de celulas tr1; kit para identificar o aislar una poblacion de celulas tr1 en reposo y/o activadas; composicion farmaceutica que comprende una poblacion de celulas tr1 en reposo y/o activadas.
MX336722B (es) Agentes de imagenologia molecular etiquetados, metodos para hacerlos y metodos de uso.
CL2008001449A1 (es) Metodo para estimular la produccion de celulas hematopoyeticas diferenciadas en un cultivo que comprende celulas progenitoras hematopoyeticas, linfocitos y monocitos/macrofagos y/o celulas dendriticas en presencia de una molecula de union especifica para una molecula coestimuladora expresada en dichas celulas.
AU316238S (en) Lawning applicator for microbiological cultures
AU315637S (en) Stand
WO2008096570A1 (ja) マイクロチップ、およびマイクロチップ検査システム
AU325012S (en) Holder
TR200705658A2 (tr) dosyasında mevcut
WO2007147975A3 (fr) Structure antigenique de surface de cellules spermatiques associee au chromosome y
DE602008002946D1 (de) Beta-carbolinarylsulfonamide, verfahren zu ihrer h
AU322104S (en) Microphone holder
UA29465U (ru) Способ футеровки барабанной мельницы
AU324401S (en) Drain inlet (Case B)
AU324013S (en) Drain inlet